Protocol · graded by use, two uses
Social connection programs for loneliness in older adults
Graded on: self-rated loneliness in older adults.
Grade C: human trials exist, but they are small, mixed or not yet repeated. This is not a finding that it does not work. How to read a grade →
At a glance
This is about group programs and other ways to help lonely older adults feel more connected. People with close ties tend to live longer, but that comes from watching people, not from testing a program. In trials, programs lowered loneliness a little, but results varied widely and the studies were weak. In one study of lonely people over 74, more people in a group program were alive 2 years later. No one has repeated that study, so the letter is C.
- What was measured
- How lonely older adults said they felt, on question scales, and in one trial, how many were alive 2 years later.
- How big
- Most programs had small effects on loneliness. In one trial of lonely older people, 97% of those in a group program were alive at 2 years against 90% of the others, about 70 more per 1,000, not yet repeated.Read from the summary of PMID PubMed ID: the permanent number the US National Library of Medicine gives a published paper. Each one links to that paper's record on PubMed. 19223606.
- Who it applies to
- Adults aged 55 to 100 living at home or in long-term care; the survival trial covered lonely adults over 74 in Finland. It does not cover younger adults.
- Safety
- The record lists no specific safety warning.
- Compared with
- Usual care or activities meant to control for attention.
- Certainty
- Grade C, resting on: Meta-analyses A study that pools the numbers from several trials into one combined estimate. of randomized trials of loneliness programs and one randomized trial with mortality; cohort studies An observational study that follows a group of people over time and compares what happens to them. described, not graded.
- What would change this grade
- Could rise to B with: Randomized trial of one defined group program against an attention control, run by a group independent of the original Finnish team. Who: Lonely adults aged 75 and older living in the community. Measured: Survival at 2 years, with loneliness measured on a validated scale as a second outcome. Length: At least 2 years of follow-up.
- Cost
- No price recorded yet.
- Sources
- 8 studies cited on this record, listed under Sources.
All two uses graded on this record carry a C, each on its own evidence.
This record carries a separate letter for each thing it has been measured on. The headline grade is the best of them, and it does not transfer to the others.
Hoang et al. (JAMA Netw Open, 2022; PMID 36251294) pooled randomized trials in 8,259 older adults: most programs had small effects and the overall quality of evidence was very low. Coppola et al. (2025; PMID 40930084) found a pooled reduction across 35 trials with extreme heterogeneity How much the results of the pooled trials differ from each other. High heterogeneity makes a combined estimate less reliable. (I2 99.6%) and a trend toward publication bias, and a 2026 network meta-analysis rated every comparison very low certainty (Liu et al.; PMID 42407321). An umbrella review found mixed or no effect where reviews did not pool (Hansen et al., 2024; PMID 39020331), and a 235-person group program found no difference in loneliness (Routasalo et al., 2009; PMID 19054177). Mixed evidence on a self-rated outcome: C.
Pitkala et al. (J Gerontol A Biol Sci Med Sci, 2009; PMID 19223606): 235 lonely adults over 74; 2-year survival 97% in the group program against 90% with usual care (p = 0.047), with better self-rated health and lower health care costs. A hard outcome, but one trial of modest size with a result near the threshold of chance, and no second trial has tested survival. Under Rule 06 a single positive trial without independent replication The same finding reproduced by a separate research group. A result seen once can be chance or bias; a replicated one is harder to explain away. is a C.
In cohort studies, people with stronger social ties live longer, and loneliness and isolation carry a mortality risk comparable to other well-known risk factors. Whether a program that builds social connection changes those outcomes is a separate question, and only randomized trials can answer it. Trials of group, psychological, animal-assisted and technology-based programs find small to moderate drops in loneliness, with very low certainty and wide variation. One trial of group rehabilitation found higher 2-year survival; no second trial has tested it. Graded by use.
Why this letter
Why this gradeGrade C, small or unreplicated trials. The reasoning, and what the grade does not cover.
Grade C on self-rated loneliness: meta-analyses of randomized trials find small to moderate reductions (PMIDs 36251294, 40930084), but the certainty is very low, the trials vary widely in what they test, an umbrella review finds mixed or no effect in narrative syntheses (PMID 39020331), and the best-described group trial found no difference in loneliness (PMID 19054177). Mixed evidence on a self-rated outcome: C. Grade C on mortality: one randomized trial of group rehabilitation in 235 lonely adults over 74 found 2-year survival of 97% against 90% (Pitkala et al., 2009; PMID 19223606); under Rule 06 a single positive trial without independent replication is a C.
WHAT THIS GRADE DOES NOT COVERthe cohort finding that people with stronger social ties live longer (PMIDs 20668659, 25910392), which describes people, not the effect of a program, and carries no letter under Rule 05; any one type of program over another, which the network meta-analysis could not settle (PMID 42407321); and younger adults.
A grade describes the human evidence for a named use. It is not advice, and it is not a judgment on any individual prescription. How the letters are decided →
Who responds: this record's trial reading reports no subgroup that identifies who responds.
Evidence notes: randomized trial, meta-analysis
Endpoint The outcome a trial measures to decide whether the treatment worked, such as heart attacks, blood pressure or a symptom score. graded: Self-rated loneliness in older adults (self_report)
Last reviewed: October 2026
The trial that would change this grade.
A positive trial of this shape, supported by further trials, would move this entry to B.
Why the current trials fall short
The survival result rests on one trial (Pitkala et al., 2009; PMID 19223606) that has not been repeated, and the loneliness trials vary widely and are of very low certainty (Hoang et al., 2022; PMID 36251294).
ClinicalTrials.gov, the public registry run by the U.S. National Library of Medicine, lists studies that are recruiting volunteers. The link below searches it for Loneliness among studies recruiting now. EBL has no relationship with any listed study and receives no payment for this link.
Search recruiting studies of Loneliness on ClinicalTrials.gov
Dose, form and timing
Measured in the graded trials: loneliness scales such as the UCLA Loneliness Scale, filled in by participants, and in one trial, survival over 2 years.
As studiedDose, form, population and duration for every use.
A grade describes the intervention that was tested. Where the product on the shelf differs from it, this says so.
Safety
No safety data. Each caution on this record, sorted by what it rests on.
None recorded.
None recorded.
None recorded.
None recorded.
No safety data: EBL has found no trial or report of harm for this record. That is an absence of evidence, not a finding of safety.
Grade history
How this letter has changedLatest: No. 384 · October 2026 · First graded.
Cohort studies link stronger social ties with longer life (Holt-Lunstad et al., 2010; PMID 20668659), but that describes people, not the effect of a program, and carries no letter. Randomized trials of programs to reduce loneliness in older adults find small to moderate effects at very low certainty (Hoang et al., 2022; PMID 36251294): C. One trial of group rehabilitation in lonely adults over 74 found higher 2-year survival (Pitkala et al., 2009; PMID 19223606), not yet repeated: C under Rule 06. Applied the written grade definitions under the editor's standing instruction of October 2026 (Arnold Sandlow, D.C.).PMID 20668659 PMID 36251294 PMID 19223606
Every change to a letter on this site is dated and published. The full evidence log →
Sources
- Citations
- Every paper cited on this page is matched to its PubMed record on every build.
- Retractions
- None of these papers is retracted or under a journal expression of concern. PubMed is checked again on every build.
- Read against the papers
- October 2026. By a language model (AI-assisted reading), not yet reviewed by a clinician.
- Outside review
- Not yet done. No reviewer outside EBL has checked this record.
What each of these checks can and cannot show: evidence integrity.
The evidence, in fullEight papers, each linked to its PubMed record.
Loneliness: Hoang et al. (JAMA Netw Open, 2022; PMID 36251294), 70 randomized trials, 8,259 adults aged 55 to 100; most interventions had small effects and the overall quality of evidence was very low; Hansen et al. (BMC Public Health, 2024; PMID 39020331), umbrella review of 29 systematic reviews A review that searches for every study on a question using a method set in advance, then assesses them together. of randomized trials, small-to-moderate benefit in meta-analyses and mixed or no effect in narrative syntheses; Coppola et al. (Ann N Y Acad Sci, 2025; PMID 40930084), 35 randomized trials, 5,291 older adults, pooled SMD -1.11 with heterogeneity I2 99.6% and a trend toward publication bias; Liu et al. (Geriatr Nurs, 2026; PMID 42407321), network meta-analysis of 45 randomized trials, 5,736 older adults, certainty of every comparison very low; Routasalo et al. (J Adv Nurs, 2009; PMID 19054177), 235 lonely adults over 74, psychosocial group program, more new friendships and better well-being but no difference in loneliness. Mortality: Pitkala et al. (J Gerontol A Biol Sci Med Sci, 2009; PMID 19223606), the same 235 adults, 2-year survival 97% against 90% (p = 0.047), with lower health care costs. Observational Research that watches what people already do rather than assigning a treatment. It can show that two things travel together, not that one causes the other., not graded (Rule 05): Holt-Lunstad et al. (PLoS Med, 2010; PMID 20668659), 148 cohort studies, 308,849 participants, 50% higher odds of survival with stronger social relationships; Holt-Lunstad et al. (Perspect Psychol Sci, 2015; PMID 25910392), social isolation, loneliness and living alone associated with 29%, 26% and 32% higher odds of death.
How EBL searched for the trials (1 search)
The search that was run, what it returned, and what was left out and why, so the absence of evidence can be checked as well as its presence.
(loneliness[ti] OR "social isolation"[ti]) AND (intervention*[tiab]) AND (meta-analysis[pt] OR systematic review[pt]) AND (randomized[tiab] OR randomized[tiab]) AND ("older adults"[tiab] OR elderly[tiab] OR "older people"[tiab])PubMed watch: does a new study change the grade? (nothing new)
No new paper matching the search behind this grade has been added to PubMed since October 2026.
Last run October 2026. A letter on EBL moves only after a logged review. A new paper never moves a letter by arriving: it is read, the answer is written here, and any change to the letter is published in the evidence log.
Disclosure
Educational use only · Not medical advice · EBL grades published human evidence and does not recommend treatment. Stopping a prescription is a decision for your physician.
Evidence Based Longevity, Inc. is owner-operated and edited by Arnold Sandlow, D.C., a California-licensed chiropractor. Evidence Based Longevity publishes in English only · Machine translations are not produced or reviewed by EBL for accuracy
© Evidence Based Longevity, Inc. All rights reserved
These statements have not been evaluated by the Food and Drug Administration. Any grade on this page describes the strength of published human trial evidence in the populations studied. It is not a recommendation for any individual and is not medical advice. Starting, stopping or changing any supplement or medication is a decision for your physician.
Grades move when new trials publish. A free monthly email lists every grade EBL moved, with the reason and the trial behind it: the sign-up is on the Evidence Log →